353 related articles for article (PubMed ID: 11229610)
41. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.
Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B
Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947
[TBL] [Abstract][Full Text] [Related]
42. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
Dawnay AB; Millar DJ
Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
[TBL] [Abstract][Full Text] [Related]
43. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
44. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
45. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags.
Cooker LA; Luneburg P; Faict D; Choo C; Holmes CJ
Perit Dial Int; 1997; 17(4):373-8. PubMed ID: 9284465
[TBL] [Abstract][Full Text] [Related]
46. Physiological saline is not a biocompatible peritoneal dialysis solution.
Wang T; Heimbürger O; Qureshi AR; Waniewski J; Bergström J; Lindholm B
Int J Artif Organs; 1999 Feb; 22(2):88-93. PubMed ID: 10212043
[TBL] [Abstract][Full Text] [Related]
47. The effects of ouabain and potassium on peritoneal fluid and solute transport characteristics.
Park MS; Lee EY; Lee NS; Waniewski J; Lindholm B; Lee HB
Perit Dial Int; 1998; 18(4):402-9. PubMed ID: 10505562
[TBL] [Abstract][Full Text] [Related]
48. The effect of dialysate acidity on peritoneal solute transport in the rat.
Park MS; Heimbürger O; Waniewski J; Werynski A; Lee HB; Bergström J; Lindholm B
Perit Dial Int; 1995; 15(8):312-9. PubMed ID: 8785228
[TBL] [Abstract][Full Text] [Related]
49. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
50. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
Opatrna S; Lysak D; Trefil L; Parker C; Topley N
Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
[TBL] [Abstract][Full Text] [Related]
51. Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.
Ho-dac-Pannekeet MM; Weiss MF; de Waart DR; Erhard P; Hiralall JK; Krediet RT
Perit Dial Int; 1999; 19 Suppl 2():S68-74. PubMed ID: 10406497
[TBL] [Abstract][Full Text] [Related]
52. Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats.
Musi B; Carlsson O; Rippe A; Wieslander A; Rippe B
Perit Dial Int; 1998; 18(3):303-10. PubMed ID: 9663895
[TBL] [Abstract][Full Text] [Related]
53. Glucose degradation products and the peritoneal mesothelium.
Jörres A; Bender TO; Witowski J
Perit Dial Int; 2000; 20 Suppl 5():S19-22. PubMed ID: 11229607
[TBL] [Abstract][Full Text] [Related]
54. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
[TBL] [Abstract][Full Text] [Related]
55. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
[TBL] [Abstract][Full Text] [Related]
56. Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.
Millar DJ; Holmes C; Faict D; Dawnay A
Adv Perit Dial; 1998; 14():191-4. PubMed ID: 10649722
[TBL] [Abstract][Full Text] [Related]
57. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
[TBL] [Abstract][Full Text] [Related]
58. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
59. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations.
Simonsen O; Venturoli D; Wieslander A; Carlsson O; Rippe B
Kidney Int; 2003 Jul; 64(1):208-15. PubMed ID: 12787411
[TBL] [Abstract][Full Text] [Related]
60. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]